EcoR1 Capital, LLC: 13F holdings
CIK 15871142026Q2
| Positions | 31 |
|---|---|
| Reported value | $2.1bn |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| ZYMEWORKS INC | 22,970,388 | $600.4m | 29.2% |
| ANAB ANAPTYSBIO INC | 7,880,094 | $531.9m | 25.9% |
| AKTIS ONCOLOGY INC | 4,824,469 | $155.5m | 7.6% |
| CG ONCOLOGY INC | 1,494,300 | $106.2m | 5.2% |
| ETON PHARMACEUTICALS INC | 2,171,938 | $78.6m | 3.8% |
| CRISPR THERAPEUTICS AG | 1,389,276 | $75.8m | 3.7% |
| ORIC PHARMACEUTICALS INC | 6,728,116 | $72.9m | 3.5% |
| FIRST TRACKS BIOTHERAPEUTICS | 3,174,519 | $63.9m | 3.1% |
| LKFT LAKEFRONT BIOTHERAPEUTICS NV | 1,667,119 | $50.0m | 2.4% |
| NEUROGENE INC | 1,271,342 | $40.0m | 1.9% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1587114")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.